Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Ferrier

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Annales De Dermatologie Et De Venereologie|April 19, 2011
[Proxy lymphomatoid contact dermatitis]V Hospital, S Amarger, F Franck, et al.
Journal of Investigational Allergology & Clinical Immunology|April 25, 2019
Rapid Desensitization to Adalimumab Is Associated With Decreased Basophil SensitivityJ Thévenot, M C Ferrier le Bouëdec, A Buisson, et al.
Annales De Medecine Interne|January 1, 1986
[Actinomyces meyeri actinomycosis: a case with thoracic and tibial localization]M C Ferrier, A Janin-Mercier, A Meyer, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1991
[Disseminated actinomycosis caused by Actinomyces meyeri. 3 cases with multiple cutaneous localizations]M C Ferrier, J M Ristori, J Beytout, et al.
Annales De Dermatologie Et De Venereologie|September 25, 1998
[Cutaneous pseudolymphoma caused by carbamazepine]M d'Incan, M L Mouillet, H Roger, et al.
Journal of the American Academy of Dermatology|November 1, 1992
Epidermolysis bullosa acquisita in a 3 1/2-year-old girlH Roger, P Machado, J F Nicolas, et al.
The British Journal of Dermatology|June 22, 2018
Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1-antihistamine treatment: results of the phase IV open-label SUNRISE studyF Bérard, M C Ferrier Le Bouedec, L Bouillet, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 17, 2021
Dupilumab-associated hypereosinophilia in patients treated for moderate-to-severe atopic dermatitisP Marcant, P Balayé, R Merhi, et al.
The British Journal of Dermatology|November 8, 2021
Reasons for discontinuation of dupilumab in adult atopic dermatitis in clinical practiceM-E Marniquet, J Seneschal, A-S Darrigade, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Annales De Dermatologie Et De Venereologie|April 19, 2011
[Proxy lymphomatoid contact dermatitis]V Hospital, S Amarger, F Franck, et al.
Journal of Investigational Allergology & Clinical Immunology|April 25, 2019
Rapid Desensitization to Adalimumab Is Associated With Decreased Basophil SensitivityJ Thévenot, M C Ferrier le Bouëdec, A Buisson, et al.
Annales De Medecine Interne|January 1, 1986
[Actinomyces meyeri actinomycosis: a case with thoracic and tibial localization]M C Ferrier, A Janin-Mercier, A Meyer, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1991
[Disseminated actinomycosis caused by Actinomyces meyeri. 3 cases with multiple cutaneous localizations]M C Ferrier, J M Ristori, J Beytout, et al.
Annales De Dermatologie Et De Venereologie|September 25, 1998
[Cutaneous pseudolymphoma caused by carbamazepine]M d'Incan, M L Mouillet, H Roger, et al.
Journal of the American Academy of Dermatology|November 1, 1992
Epidermolysis bullosa acquisita in a 3 1/2-year-old girlH Roger, P Machado, J F Nicolas, et al.
The British Journal of Dermatology|June 22, 2018
Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1-antihistamine treatment: results of the phase IV open-label SUNRISE studyF Bérard, M C Ferrier Le Bouedec, L Bouillet, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 17, 2021
Dupilumab-associated hypereosinophilia in patients treated for moderate-to-severe atopic dermatitisP Marcant, P Balayé, R Merhi, et al.
The British Journal of Dermatology|November 8, 2021
Reasons for discontinuation of dupilumab in adult atopic dermatitis in clinical practiceM-E Marniquet, J Seneschal, A-S Darrigade, et al.
Pageof 2